Over the past year, development impact bonds, or DIBs—international development’s newest hot trend—have generated a tremendous amount of buzz from champions and detractors alike, along with some ...

Quality evidence is needed to support a new Medicare Part D medication therapy management (MTM) program performance measure, prompting a scoping review on MTM services and associated outcomes.

Despite increased investments in talent and learning development (L&D), most organizations struggle to provide the metrics that CEOs and business leaders care about most: impact and return on ...